Common variable immune deficiency syndrome associated with lupus anticoagulant

Area of Science:

• Hematology
• Immunology
• Virology

Background:

• Acquired immune deficiency syndrome (AIDS) is associated with various hematological complications.
• Lupus anticoagulants are antiphospholipid antibodies that can cause thrombotic events.
• Previous studies suggested lupus anticoagulants primarily target phospholipids.

Observation:

• A patient diagnosed with AIDS presented with a lupus anticoagulant.
• The anticoagulant's inhibitory activity was solely detected as a prolonged partial thromboplastin time.
• Standard assays involving platelet substitution or sonicates did not correct the clotting abnormality.

Findings:

• The observed inhibitor did not demonstrate immunoreactivity against phospholipids.
• This finding contradicts the established understanding of lupus anticoagulant mechanisms.
• The inhibitor's unique characteristics suggest novel pathogenic pathways.

Implications:

• This case highlights the heterogeneity of lupus anticoagulants in immunocompromised patients.
• Understanding atypical anticoagulant mechanisms is crucial for accurate diagnosis and management.
• Further research is needed to elucidate the specific targets and actions of such inhibitors.